Eduardo Gil De Rubio, MD | |
202 N Division St, Auburn, WA 98001-4939 | |
(253) 833-7711 | |
Not Available |
Full Name | Eduardo Gil De Rubio |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 202 N Division St, Auburn, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023183522 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MD00040179 (Washington) | Primary |
Entity Name | 24 On Physicians Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912956251 PECOS PAC ID: 5698688141 Enrollment ID: O20031216000444 |
News Archive
BD Diagnostics announced today the expansion of its portfolio of tools to prevent and control infectious diseases by adding software systems for the surveillance of infections and associated risk factors among patients and healthcare workers, and in the community.
According to a recent study, one in five hospital discharges is complicated by an adverse event within 30 days, often leading to emergency care or re-hospitalization. To combat this problem, CIGNA (NYSE:CI) and CareCentrix, Inc., have teamed up to offer the Care Transitions Program to people enrolled in a CIGNA health plan after they've been discharged from the hospital. CareCentrix will provide specialized home nursing services that will help these individuals transition from hospital care to home recovery.
Kaiser Health News staff writer Mary Agnes Carey and the Kaiser Family Foundation's Jackie Judd discuss the health care summit between President Obama, Republicans and Democrats. The forum ended with the president laying out some areas of consensus between the two parties but many disagreements remain (Kaiser Health News).
Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system. This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Eduardo Gil De Rubio, MD 1012 W Fulton St, Seattle, WA 98119-2243 Ph: () - | Eduardo Gil De Rubio, MD 202 N Division St, Auburn, WA 98001-4939 Ph: (253) 833-7711 |
News Archive
BD Diagnostics announced today the expansion of its portfolio of tools to prevent and control infectious diseases by adding software systems for the surveillance of infections and associated risk factors among patients and healthcare workers, and in the community.
According to a recent study, one in five hospital discharges is complicated by an adverse event within 30 days, often leading to emergency care or re-hospitalization. To combat this problem, CIGNA (NYSE:CI) and CareCentrix, Inc., have teamed up to offer the Care Transitions Program to people enrolled in a CIGNA health plan after they've been discharged from the hospital. CareCentrix will provide specialized home nursing services that will help these individuals transition from hospital care to home recovery.
Kaiser Health News staff writer Mary Agnes Carey and the Kaiser Family Foundation's Jackie Judd discuss the health care summit between President Obama, Republicans and Democrats. The forum ended with the president laying out some areas of consensus between the two parties but many disagreements remain (Kaiser Health News).
Could engineered human stem cells hold the key to cancer survival? Scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have discovered that neural stem cells possess the innate ability to target tumor cells outside the central nervous system. This finding, which was demonstrated successfully on breast cancer cells, was recently published in leading peer reviewed journal, Stem Cells.
› Verified 9 days ago
Dr. Robert Todd Middleton, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 202 N Division St, Ste 201, Auburn, WA 98001 Phone: 253-939-1230 Fax: 253-735-1211 | |
Abdul R Siddiqui, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St Ste 301, Auburn, WA 98001 Phone: 253-288-3040 | |
Dr. Krystoff J. Godlewski, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 202 N Division St, Plaza 2 Suite 201, Auburn, WA 98001 Phone: 253-939-1230 Fax: 253-735-6479 | |
Iliana Domenica Micali, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 309 2nd St Se, Ste 100, Auburn, WA 98002 Phone: 253-333-8646 | |
Dr. James Martin Wagner, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 202 N Division St, Plaza 2 Suite 201, Auburn, WA 98001 Phone: 253-939-1230 | |
Madhavi Reddy Mandala, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St Ste 301, Auburn, WA 98001 Phone: 253-833-7256 |